Upgraded services in Mumbai, plus an existing Chennai PoP, strengthen options for performance, compliance, and connected architectures across India. MUMBAI, India,…
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to…